Fresenius Debuts Subcutaneous Tocilizumab Biosimilar In US

Launches SC Version Of Tyenne Alongside Existing Intravenous Presentation

 
• By Dave Wallace
  
Fresenius Kabi logo on building
Fresenius Kabi has launched a new presentation of Tyenne • Source: Shutterstock

More from Biosimilars

More from Products